Compared to proliferative CD8+T cells which were increased in COVID-19 patients, most T and NK cell subsets (e.g., CD4_Treg, CD4_Th1, CD4_Th2, γδT, NK_CD56(dim)) decreased, especially for those displaying severe disease and acute necrotizing encephalopathy. This evidence concerns the gene NCAM1 and COVID-19.